HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitsuhiko Moriyama Selected Research

Indicators and Reagents (Reagents)

11/2012Use of a highly sensitive latex reagent with amino acid spacer for determination of C-reactive protein concentration in a variety of liver diseases.
8/2002Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitsuhiko Moriyama Research Topics

Disease

32Hepatocellular Carcinoma (Hepatoma)
07/2022 - 04/2002
31Infections
07/2022 - 12/2006
24Chronic Hepatitis C
07/2021 - 11/2002
21Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 01/2003
18Liver Diseases (Liver Disease)
05/2022 - 11/2001
17Neoplasms (Cancer)
07/2022 - 12/2002
11Chronic Hepatitis (Chronic Active Hepatitis)
11/2021 - 08/2002
9Hepatitis
05/2022 - 08/2002
7Fibrosis (Cirrhosis)
07/2022 - 08/2002
6Hepatitis C
01/2009 - 06/2002
5Stomach Neoplasms (Stomach Cancer)
02/2022 - 10/2008
5Hepatitis B
10/2019 - 01/2003
4Acute Liver Failure (Fulminant Hepatic Failure)
05/2022 - 01/2013
4Liver Failure
06/2021 - 01/2003
4Chronic Hepatitis B
02/2010 - 01/2003
3Inflammation (Inflammations)
04/2020 - 09/2004
3Autoimmune Hepatitis
02/2018 - 01/2004
3Carcinogenesis
07/2016 - 12/2002
2Pathologic Constriction (Stenosis)
10/2022 - 05/2018
2Pancreatitis
10/2022 - 10/2017
2Esophageal and Gastric Varices (Esophageal Varices)
01/2022 - 11/2014
2Adenocarcinoma
12/2021 - 08/2020
2Ascites
07/2021 - 07/2014
2Obesity
03/2021 - 01/2019
2Alcoholism (Alcohol Abuse)
03/2021 - 10/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2020 - 04/2020
2Neoplasm Metastasis (Metastasis)
09/2020 - 10/2008
2Ulcerative Colitis
09/2020 - 05/2010
2Coinfection
11/2019 - 11/2001
2Persistent Infection
10/2019 - 02/2007
2Non-alcoholic Fatty Liver Disease
01/2019 - 07/2018
2Hepatic Encephalopathy
07/2018 - 07/2014
2Exanthema (Rash)
06/2018 - 01/2016
2Alcoholic Fatty Liver
05/2018 - 01/2013
2Virus Diseases (Viral Diseases)
01/2018 - 12/2006
2Hemorrhage
02/2016 - 05/2015
2Latent Tuberculosis
01/2016 - 01/2015
2Tuberculosis (Tuberculoses)
01/2016 - 01/2015
2Autoimmune Diseases (Autoimmune Disease)
01/2016 - 01/2004
2Disease Progression
01/2013 - 12/2006
1Necrosis
07/2022
1COVID-19
07/2022

Drug/Important Bio-Agent (IBA)

21InterferonsIBA
07/2022 - 01/2003
18Antiviral Agents (Antivirals)IBA
07/2022 - 12/2002
10RNA (Ribonucleic Acid)IBA
08/2020 - 11/2001
9Proteins (Proteins, Gene)FDA Link
05/2022 - 09/2004
9DNA (Deoxyribonucleic Acid)IBA
01/2020 - 08/2002
6ZincIBA
07/2021 - 11/2006
5Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2019 - 06/2002
4CytokinesIBA
05/2022 - 01/2017
4VaccinesIBA
01/2021 - 01/2018
4Biomarkers (Surrogate Marker)IBA
07/2020 - 02/2007
4Ribavirin (Virazole)FDA LinkGeneric
01/2016 - 06/2006
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2022 - 12/2002
3Immune Checkpoint InhibitorsIBA
12/2021 - 09/2020
3Pharmaceutical PreparationsIBA
07/2021 - 03/2016
3Toll-Like Receptors (Toll-Like Receptor)IBA
07/2021 - 05/2020
3SteroidsIBA
06/2021 - 01/2004
3entecavirFDA Link
02/2010 - 09/2008
3Interferon-alpha (Interferon Alfa)IBA
01/2009 - 01/2005
3AntibodiesIBA
02/2007 - 04/2002
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
01/2005 - 08/2002
2lenvatinibIBA
07/2022 - 05/2020
2Subgenomic RNAIBA
05/2022 - 02/2022
2favipiravirIBA
05/2022 - 02/2022
2NucleotidesIBA
02/2022 - 05/2004
2Hepatitis A AntibodiesIBA
02/2022 - 12/2020
2Bevacizumab (Avastin)FDA Link
12/2021 - 01/2021
2atezolizumabIBA
12/2021 - 01/2021
2NivolumabIBA
12/2021 - 09/2020
2glecaprevir and pibrentasvirIBA
11/2021 - 07/2021
2Alanine Transaminase (SGPT)IBA
11/2021 - 02/2005
2zinc chlorideFDA Link
07/2021 - 11/2020
2Phosphotransferases (Kinase)IBA
05/2020 - 03/2019
2Serum AlbuminIBA
02/2020 - 11/2012
2NucleosidesIBA
10/2019 - 02/2009
2IronIBA
05/2018 - 11/2002
2SofosbuvirIBA
01/2018 - 01/2017
2ledipasvirIBA
01/2018 - 01/2017
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2017 - 05/2014
2miriplatinIBA
07/2016 - 03/2016
2Immunoglobulin G (IgG)IBA
01/2016 - 04/2009
2Indicators and Reagents (Reagents)IBA
11/2012 - 08/2002
2Amino AcidsFDA Link
11/2012 - 12/2004
2Lamivudine (Epivir)FDA Link
02/2010 - 09/2008
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2009 - 01/2006
2Immunoglobulins (Immunoglobulin)IBA
04/2009 - 12/2006
2Fluorouracil (Carac)FDA LinkGeneric
10/2008 - 06/2006
2AntigensIBA
01/2005 - 09/2004
1LuciferasesIBA
05/2022
1RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
05/2022
1Suppressor of Cytokine Signaling ProteinsIBA
05/2022

Therapy/Procedure

32Therapeutics
07/2022 - 01/2003
3Catheters
10/2022 - 03/2016
3Drug Therapy (Chemotherapy)
02/2019 - 02/2007
2Aftercare (After-Treatment)
07/2022 - 01/2019
2Liver Transplantation
05/2022 - 02/2016
2Blood Transfusion (Blood Transfusions)
03/2019 - 02/2007
2Retreatment
03/2018 - 01/2018
1Stents
10/2022